Apyx Medical (NASDAQ:APYX) will release its earnings data after the market closes on Wednesday, May 8th. Analysts expect Apyx Medical to post earnings of ($0.19) per share for the quarter. Apyx Medical has set its FY 2019 guidance at EPS.
Apyx Medical (NASDAQ:APYX) last announced its earnings results on Wednesday, March 13th. The company reported ($0.10) earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of ($0.10). Apyx Medical had a net margin of 206.55% and a negative return on equity of 8.95%. The business had revenue of $5.93 million for the quarter, compared to the consensus estimate of $5.95 million. During the same quarter in the prior year, the firm posted ($0.09) earnings per share. The business’s revenue for the quarter was up 62.0% on a year-over-year basis. On average, analysts expect Apyx Medical to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Shares of APYX opened at $5.77 on Tuesday. Apyx Medical has a twelve month low of $3.54 and a twelve month high of $8.89. The firm has a market capitalization of $181.77 million, a PE ratio of -19.93 and a beta of 0.24.
Several brokerages have recently weighed in on APYX. ValuEngine raised shares of Apyx Medical from a “buy” rating to a “strong-buy” rating in a research note on Monday, April 29th. Dougherty & Co reduced their target price on shares of Apyx Medical from $12.00 to $9.00 and set a “buy” rating on the stock in a research note on Tuesday, April 2nd. JMP Securities reduced their target price on shares of Apyx Medical from $12.00 to $8.00 and set a “market outperform” rating on the stock in a research note on Tuesday, April 2nd. Zacks Investment Research downgraded shares of Apyx Medical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 18th. Finally, Piper Jaffray Companies increased their target price on shares of Apyx Medical to $10.00 and gave the company an “overweight” rating in a research note on Monday, February 11th. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus price target of $9.00.
TRADEMARK VIOLATION WARNING: “Apyx Medical (APYX) to Release Quarterly Earnings on Wednesday” was originally posted by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.thelincolnianonline.com/2019/05/07/apyx-medical-apyx-to-release-quarterly-earnings-on-wednesday.html.
Apyx Medical Company Profile
Apyx Medical Corporation, a medical technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates through two segments, Advanced Energy and original equipment manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue.
Featured Story: What is a Lock-Up Period?
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.